安捷凯在线客服
- 客服:
- 电话: 13061953619
- 微信:
BGG463 (K03859) 是一种具有口服活性的 II 型 CDK2 抑制剂。
BGG463 (K03859) is an orally active type II CDK2 inhibitor[1].
BGG463 potently inhibits T315I BCR–ABL autophosphorylation and shows good oral efficacy in mouse models of CML[2].
参考文献:
[1]. Alexander LT, et al. Type II Inhibitors Targeting CDK2. ACS Chem Biol. 2015 Sep 18;10(9):2116-25.
[2]. Jones K, et al. Cancer Drug Discovery 2010: from molecules to medicine. Expert Rev Clin Pharmacol. 2010 Sep;3(5):613-5.
动态评分
0.0